SEC Charges Company and Two Executives for Misleading COVID-19 Disclosures

The Securities and Exchange Commission today announced charges against Parallax Health Sciences Inc. for making misleading statements about its efforts to fight COVID-19.  The SEC also charged Parallax’s Chief Executive Officer Paul Arena and its…

Read the Full Press Release

Have a securities law question? Call Sallah Astarita & Cox at 212-509-6544.

+ posts
The Securities Lawyer